Korean J Urol.  2015 Jun;56(6):409-411. 10.4111/kju.2015.56.6.409.

Current status of stem cell therapy in urology

• Kim JH
• Song YS

• KMID: 2160579
• DOI: http://doi.org/10.4111/kju.2015.56.6.409

Abstract

No abstract available.

MeSH Terms

Animals
Erectile Dysfunction/therapy
Humans
Male
Stem Cell Transplantation/*methods
Urologic Diseases/*therapy
Urology/methods/trends

Reference

1. Kim JH, Lee HJ, Song YS. Treatment of bladder dysfunction using stem cell or tissue engineering technique. Korean J Urol. 2014; 55:228–238.

2. Kim JH, Lee SR, Song YS, Lee HJ. Stem cell therapy in bladder dysfunction: where are we? And where do we have to go? Biomed Res Int. 2013; 2013:930713.

3. Alwaal A, Hussein AA, Lin CS, Lue TF. Prospects of stem cell treatment in benign urological diseases. Korean J Urol. 2015; 56:257–265.

4. Kim JH, Shim SR, Doo SW, Yang WJ, Yoo BW, Kim JM, et al. Bladder recovery by stem cell based cell therapy in the bladder dysfunction induced by spinal cord injury: systematic review and meta-analysis. PLoS One. 2015; 10:e0113491.

5. Shan H, Chen F, Zhang T, He S, Xu L, Wei A. Stem cell therapy for erectile dysfunction of cavernous nerve injury rats: a systematic review and meta-analysis. PLoS One. 2015; 10:e0121428.

6. Lee HJ, Doo SW, Kim DH, Cha YJ, Kim JH, Song YS, et al. Cytosine deaminase-expressing human neural stem cells inhibit tumor growth in prostate cancer-bearing mice. Cancer Lett. 2013; 335:58–65.

7. Wang L, Zhang Y, Zhao J, Xiao E, Lu J, Fu S, et al. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro. Tumour Biol. 2014; 35:10879–10890.